AstraZeneca
1.697,5 SEK +1,8%17 investorer følger denne virksomhed
AstraZeneca is a global biopharmaceutical company that focuses on the research, development, and marketing of prescription drugs, primarily for the treatment of diseases in the areas of therapy that affect the respiratory tract, cardiovascular / metabolism, and cancer. In addition to its main operations, the company is also active in autoimmunity, neuroscience, and infection. AstraZeneca is active in all global regions and is headquartered in Cambridge.
Omsætning
-
EBIT %
-
P/E
43,82
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
AZN
Daglig lav / høj pris
1.683,5 / 1.713
SEK
Markedsværdi
2,63 bio. SEK
Aktieomsætning
317,78 mio. SEK
Volumen
187 t
Finanskalender
Halvårligt udbytte
08.08.2024
Delårsrapport
12.11.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
BlackRock, Inc. | 7,0 % | 7,0 % |
The Capital Group Companies | 5,0 % | 5,0 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
AstraZeneca: Filing of Form 20-F with SEC
AstraZeneca: 9M and Q3 2023 results
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools